Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy.

Tesfai, Yordanos

Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy. [electronic resource] - Leukemia research Mar 2012 - 299-306 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

1873-5835

10.1016/j.leukres.2011.08.001 doi


Antigens, CD34--metabolism
Antimetabolites, Antineoplastic--pharmacology
Antineoplastic Agents--pharmacology
Antineoplastic Agents, Hormonal--pharmacology
Antineoplastic Agents, Phytogenic--pharmacology
Asparaginase--pharmacology
Biomarkers, Tumor--genetics
Bone Marrow Cells--drug effects
Case-Control Studies
Cell Communication--drug effects
Cell Survival--drug effects
Cells, Cultured
Child
Cohort Studies
Cytarabine--pharmacology
Dexamethasone--pharmacology
Gene Expression Profiling
Humans
Neoplasm Staging
Oligonucleotide Array Sequence Analysis
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Principal Component Analysis
Prognosis
RNA, Messenger--genetics
Real-Time Polymerase Chain Reaction
Stromal Cells--drug effects
Vincristine--pharmacology